Skip to content

Fulgent Genetics, Inc. FLGT Ratios & Valuation

FY'25FY'24FY'23FY'22
Profitability
Gross margin40.6%+2.7pp37.8%+1.7pp36.1%-23.2pp59.3%-19.0pp
Operating margin-28.2%-2.2pp-26.1%+41.5pp-67.6%-96.5pp28.8%-39.3pp
Net margin-18.8%-3.7pp-15.1%+43.0pp-58%-81.2pp23.2%-27.9pp
EBITDA margin-20.8%-3.5pp-17.3%+41.3pp-58.6%-92.7pp34.1%-35.1pp
Free cash flow margin-40.1%1.7%-36.3pp37.9%-13.9pp
Returns
Return on equity-5.4%-1.6pp-3.8%+10.2pp-14%-25.8pp11.8%-46.9pp
Return on assets-5%-1.5pp-3.5%+9.3pp-12.8%-23.6pp10.8%-40.5pp
Return on invested capital-8.5%-1.5pp-6.9%+10.4pp-17.3%-29.8pp12.5%-55.0pp
Efficiency
Asset turnover0.3×0.0×0.2×0.0×0.2×-0.2×0.5×-0.5×
Liquidity
Current ratio6.5×+1.6×4.9×-2.1×-0.2×7.1×+1.3×
Quick ratio6.5×+1.6×4.9×-2.1×-0.2×7.1×+1.3×
Cash ratio0.6×-0.2×0.8×-0.6×1.3×+0.4×0.9×-0.7×
Leverage
Debt-to-equity0.0×0.0×0.0×0.0×
Debt-to-assets0.0×0.0×0.0×0.0×
Interest coverage-1,214.6×176.4×
Per Share
Book value per share$36.13-3.6%$37.48-1.7%$38.14-6.8%$40.91+9.4%
Valuation
Market capitalization$552.11M-7.1%$564.94M-34.1%$856.69M-4.8%$900.1M-70.0%
Enterprise value$536.92M+0.7%$516.12M-33.1%$771.63M-8.0%$838.28M-70.5%
Price / sales1.7×-0.3×-1.0×+1.5×1.5×-1.6×
Price / book0.5×0.0×0.5×-0.3×0.8×0.0×0.7×-1.9×
EV / sales1.7×-0.1×1.8×-0.8×2.7×+1.3×1.4×-1.5×
Free cash flow yield-21.4%0.6%-25.5pp26.1%+8.9pp
Earnings yield-13.4%-6.5pp-7.6%+12.0pp-19.6%-35.5pp15.9%-1.0pp

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

What are Fulgent Genetics, Inc.'s profit margins?
Fulgent Genetics, Inc. (FLGT) runs a 38.7% gross margin and a -33.1% operating margin, with a -23.0% net margin.
Where do Fulgent Genetics, Inc.'s ratios come from?
Every ratio is computed from Fulgent Genetics, Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.